A free flu jab will be available to all NSW residents in a month-long blitz from 1 June to 30 June 2022 to this year’s expected severe influenza season. With a sharp increase in flu cases already, the NSW Government will fund flu vaccinations at general practice and pharmacies for those who are not otherwise eligible for free flu vaccinations under the NIP.
COVID-19 winter boosters are also recommended for specific population groups (see expanded ATAGI recommendations), and providers are reminded that both flu and COVID-19 vaccines can be administered at the same time.
The NSW flu program will complement the current National Immunisation Program (NIP), funded by the Commonwealth, which provides free flu vaccine for those considered to be at higher risk of severe illness from the flu, including:
Aboriginal and Torres Strait Islander people from six months of age
children from six months to under five years of age
people ages 5 to 64 years with serious health conditions (including severe asthma, diabetes, cancer, immune disorders, obesity, kidney, heart, lung or liver disease)
people aged 65 and over.
GPs will be able to obtain FluQuadri (state funded) from the State Vaccine Centre for this expanded program in June. GPs should continue to prioritise NIP supplies (Vaxigrip, Fluarix and Afluria) for eligible patients.
GPs can also use private stock and seek remuneration for the purchase cost via a declaration of quantities administered at the conclusion of the program on 30 June 2022.
NSW Health has lowered the minimum age permitted for children to receive flu vaccines in pharmacies to 5 years old (previously 10 years old) making it easier for families to be vaccinated together.
Pharmacies are encouraged to use existing private supply or obtain vaccine supply through usual wholesale supply distributers for under 65s. During the month of June pharmacies will be remunerated for vaccines administered.
Unlike routine NIP vaccine orders (via the NSW Vaccine Centre), there is no limit on the number of flu vaccine orders that can be placed per month. There is also no restriction on the quantities of flu vaccines that can be ordered once pre-allocated and pre-ordered vaccine has been distributed at the start of the season.
Providers are reminded to log into their vaccine account and confirm receipt of each vaccine delivery. New orders cannot be placed until this has been done. (This requirement has been in place since December 2020.)
Providers should contact the State Vaccine Centre on 1300 656 132 for issues relating to vaccine ordering.
Updated COVID-19 vaccine flowchart
The ATAGI COVID-19 vaccine flowchart outlines which vaccines and doses are recommended for each age group and population group. The flowchart was updated 27 May to include:
Winter boosters for people aged 16 – 64 years who have complex, chronic or severe conditions that are considered to increase their risk of severe illness from COVID-19
Additional foot notes
Winter booster for at-risk people aged 16 to 64 years
People aged 16 to 64 years at increased risk of severe COVID-19 are now recommended to receive a winter booster vaccination dose. Additional groups recommended for a winter booster dose are listed in Table 1 however, providers may use clinical judgment to include individuals with similar conditions.
The additional groups are likely to have an ongoing increased risk of severe COVID-19 even after primary vaccination, and include people aged 16 to 64 years with:
Specific chronic inflammatory conditions
Chronic lung disease
Chronic liver disease
Severe chronic kidney disease
Chronic neurological disease
Diabetes requiring medication
Chronic cardiac disease
People with disability
Considerations for younger people
Younger people aged 16 to 40 years with increased risk of severe COVID-19 may consider discussing the potential risks and benefits of a second booster dose with their doctor. There is a very rare risk of myocarditis and pericarditis after mRNA vaccines which is highest in this age group, particularly in males. It is anticipated that this cohort may have an increased risk of myocarditis or pericarditis following the second booster, compared with other population groups. See ATAGI advice on Myocarditis and Pericarditis.
COVID-19 live stream update for GPs
COVID-19 vaccinelive stream for GPs – key updates and live Q&A
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…